Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).
about
Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS).Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database.
P2860
Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Comparison of brand versus gen ...... vent Reporting System (FAERS).
@en
Comparison of brand versus gen ...... Adverse Event Reporting System
@nl
type
label
Comparison of brand versus gen ...... vent Reporting System (FAERS).
@en
Comparison of brand versus gen ...... Adverse Event Reporting System
@nl
prefLabel
Comparison of brand versus gen ...... vent Reporting System (FAERS).
@en
Comparison of brand versus gen ...... Adverse Event Reporting System
@nl
P2093
P2860
P1433
P1476
Comparison of brand versus gen ...... vent Reporting System (FAERS).
@en
P2093
Annya V Plotkina
David Page
Jingjing Qian
Md Motiur Rahman
Ning Cheng
Peggy L Peissig
Richard A Hansen
Richard L Berg
Yasser Alatawi
P2860
P356
10.1016/J.EPLEPSYRES.2017.06.007
P577
2017-06-13T00:00:00Z